Research.Patient.info
Autosomal Recessive Polycystic Kidney Disease research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 days to less than 12 weeks of Age with Autosomal Recessive Polycystic Kidney Disease (ARPKD).
This study is looking at a medicine called Tolvaptan for babies and young children (28 days to under 12 weeks old) with a kidney condition called Autosomal Recessive Polycystic Kidney Disease (ARPKD). We want to see if Tolvaptan is safe, if it helps their kidneys, and how well it's tolerated.
Belgium · Spain · Germany - recruiting
National Registry of Rare Kidney Diseases
This registry is collecting information from people with rare kidney diseases across the UK. It aims to improve understanding, create better care guidelines, and help develop new treatments for these conditions. If you have a rare kidney disease, your information could help.
United Kingdom